Literature DB >> 17640715

Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.

Koichi Nakamura1, Yoh Zen, Yasunori Sato, Kazuto Kozaka, Osamu Matsui, Kenichi Harada, Yasuni Nakanuma.   

Abstract

Dysplastic nodules (DNs) are regarded as a premalignant lesion of hepatocellular carcinoma (HCC). Sinusoidal capillarization and unpaired arteries are reported in HCC and also to a lesser degree in DN. However, the mechanism and significance of these vascular alterations remain unclear. In this study, these vascular changes were examined with respect to vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1), hypoxia inducible factor-1alpha (HIF-1alpha), and CD34, by using 20 surgically resected cases of DNs and 36 cases of conventional HCC. The expression of these molecules was examined immunohistochemically. Although sinusoidal capillarization characterized by CD34 expression was found diffusely in HCC, such changes were found mainly in the areas around the portal tracts and also in other areas in DNs (focal in 6 cases, zonal in 7 cases, and extensive distribution in 7 cases). These capillarized areas were frequently associated with unpaired arteries, and the infiltration of neoplastic hepatocytes into the portal tracts and loss of reticulin fibers in DNs, particularly those with a zonal and extensive distribution. VEGF was diffusely expressed in neoplastic hepatocytes of DNs and HCC. Interestingly, Flk-1 and HIF-1alpha were mostly expressed in endothelial cells and neoplastic hepatocytes in the capillarized areas around portal tracts in DNs, respectively. In conclusion, the capillarized areas with increased numbers of unpaired arteries in DNs may represent an early malignant transformation. Increased expression of Flk-1 and HIF-1alpha associated with VEGF may be involved in sinusoidal capillarization and the increased numbers of unpaired arteries in these areas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640715     DOI: 10.1016/j.humpath.2007.03.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

Review 1.  Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization.

Authors:  Osamu Matsui
Journal:  Clin Drug Investig       Date:  2012-08-08       Impact factor: 2.859

2.  A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes.

Authors:  Jianfei Huang; Yang Tan; Qi Tang; Xinjian Liu; Xiaohong Guan; Zhenqing Feng; Jin Zhu
Journal:  Cytotechnology       Date:  2010-04-13       Impact factor: 2.058

3.  Hemodynamics and progression of a hypervascular focus in a borderline lesion of hepatocellular carcinoma: analysis by angiography-assisted CT and histopathology.

Authors:  Tamao Endo; Kazuto Kozaka; Satoshi Kobayashi; Junichiro Sanada; Wataru Koda; Tetsuya Minami; Azusa Kitao; Norihide Yoneda; Yasuni Nakanuma; Toshifumi Gabata; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2013-12-12       Impact factor: 2.374

Review 4.  Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.

Authors:  Bharath Nath; Gyongyi Szabo
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 5.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

6.  Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.

Authors:  Y Tian; B Guo; H Jia; K Ji; Y Sun; Y Li; T Zhao; L Gao; Y Meng; D V Kalvakolanu; D J Kopecko; X Zhao; L Zhang; D Xu
Journal:  Cancer Gene Ther       Date:  2012-05-04       Impact factor: 5.987

7.  The patterns and expression of KDR in normal tissues of human internal organs.

Authors:  Jianfei Huang; Huijun Zhu; Xudong Wang; Qi Tang; Hua Huang; Kerong Wu; Jin Zhu; Zhenqing Feng; Gongshen Shi
Journal:  J Mol Histol       Date:  2011-09-10       Impact factor: 2.611

8.  Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.

Authors:  Ji-An Chen; Ming Shi; Jin-Qing Li; Chao-Nan Qian
Journal:  Hepatol Int       Date:  2010-07-29       Impact factor: 6.047

9.  Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.

Authors:  Yosui Tamaki; Yukiomi Nakade; Taeko Yamauchi; Yuichi Makino; Shiro Yokohama; Mitsuyoshi Okada; Kazunobu Aso; Hiroyuki Kanamori; Tomohiko Ohashi; Ken Sato; Haruhisa Nakao; Masakazu Haneda; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2012-08-14       Impact factor: 7.527

10.  Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Yanqiong Liu; Jingzhe Sui; Limin Zhai; Shi Yang; Li Huang; Liying Huang; Cuiju Mo; Junrong Wu; Shan Li; Xue Qin
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.